Analyzing bone marrow and peripheral blood in flow cytometry, the most distinctive feature of GATA2-related MDS seems to be the reduction of B cells, compared to healthy controls, aplastic anemia, and MDS patients without GATA2 deficiency. This evidence concerns the gene GATA2 and myelodysplastic syndrome.